Drug delivery tech maker GeNO files for IPO of up to $50M November 14, 2013 By drugdelivery Waltham, Mass.-based GeNO LLC is hoping to raise as much as $50 million through an initial public offering, with funds slated to further development and commercialization of the company’s GeNOsyl drug delivery technology.